Kercheville Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kercheville Advisors's LLY Position: Q3 2026 in Review
Kercheville Advisors increased its Eli Lilly (LLY) stake by 2.6% in Q3 2026, buying an estimated $184K and bringing the position to 6,157 shares worth $7.12M. The position accounts for 1.97% of the portfolio, ranked #20.
Kercheville Advisors first reported a position in LLY in Q1 2022 and has held it in 15 quarters since. The position peaked at $7.57M in Q3 2024. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Kercheville Advisors held 6,157 shares of Eli Lilly worth $7.12M as of Q3 2026.
- Kercheville Advisors bought 156 Eli Lilly shares in Q3 2026, an estimated $184K.
- Eli Lilly made up 1.97% of Kercheville Advisors's portfolio in Q3 2026, its #20 holding.
- Kercheville Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 15 quarters since.
- Kercheville Advisors's Eli Lilly position peaked at $7.57M in Q3 2024.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Kercheville Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.